NUMDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nu-Med Plus, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026
- Market cap
- $601.55K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0228 (−76.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $601.55K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$56.18K
- EPS, diluted
- $0.00
- Book value per share
- -$0.00
- Diluted shares
- 84M
Fifteen years at a glance
Fiscal years 2011 to 2025, USD
Revenue
–
Operating income
-$48.96K
Net income
-$56.18K
EPS, diluted
$0.00
Free cash flow
–
Reported period